Ligand validation:3LMY

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3LMY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LMY_NAG_B_560	15%	23%	0.321	0.882	0.71	2.39	-	7	0	0	100%	0.9333
3LMY_NAG_B_559	5%	14%	0.357	0.777	1.33	2.48	1	4	0	0	100%	0.9333
3LMY_NAG_A_561	1%	8%	0.499	0.656	1.35	3.15	2	8	0	0	100%	0.9333
2GJX_NAG_E_723	30%	69%	0.124	0.787	0.46	0.71	-	-	0	0	100%	0.9333
1O7A_NAG_A_702	4%	65%	0.339	0.705	0.69	0.67	-	-	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_C_1002	100%	69%	0.022	0.994	0.55	0.65	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.